What are the risks of a two‑vessel (single‑artery) umbilical cord in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Two-Vessel Cord (Single Umbilical Artery) Pregnancy Risks

A two-vessel umbilical cord (single umbilical artery) carries significant risks for stillbirth, fetal growth restriction, and structural anomalies—particularly cardiac and renal—requiring targeted surveillance and management even when isolated.

Key Risk Stratification

The critical distinction is whether the single umbilical artery (SUA) is isolated versus associated with other abnormalities:

When SUA Occurs WITH Other Structural Abnormalities

  • Aneuploidy risk: 4-50% 1
  • Most commonly affects cardiovascular and renal systems 1
  • Requires comprehensive cardiac anatomy assessment (76811 ultrasound) 1
  • Fetal echocardiography is NOT routinely needed if cardiac views are adequately visualized and normal 1

When SUA is Isolated (No Other Abnormalities)

  • No increased aneuploidy risk 1
  • No additional aneuploidy evaluation recommended, regardless of prior screening results 1

Mortality and Morbidity Risks in Isolated SUA

Despite being "isolated," this finding carries substantial risks:

Stillbirth Risk

  • 4.8-fold increased odds of stillbirth (OR 4.80,95% CI 2.67-8.62) 1
  • 5.6-fold increased risk of perinatal and intrauterine death (OR 5.62,95% CI 4.69-6.73) 2

Fetal Growth Restriction

  • 73% increased risk of preterm birth 2
  • 55% increased risk of small-for-gestational-age neonate 2
  • Evidence is conflicting, with some studies showing increased FGR risk and others not 1
  • Multiple studies confirm 2-4 fold increased risk of intrauterine growth restriction 3, 4, 5

Other Pregnancy Complications

  • Increased risk of: polyhydramnios, oligohydramnios, placental abruption, cord prolapse, and perinatal mortality 1
  • 3.5-fold increased risk of pregnancy-induced hypertension 3
  • 7.4-fold increased risk of medically indicated preterm birth 3
  • Placental abnormalities occur 3.6 times more frequently 6

Postnatal Findings

  • Up to 7% of infants with prenatal diagnosis of isolated SUA have structural anomalies detected postnatally 1

Required Management Protocol

Given the conflicting evidence but clear increased stillbirth risk, the following surveillance is mandatory 1:

  1. Third-trimester ultrasound to evaluate fetal growth (GRADE 1C recommendation)

  2. Weekly antenatal fetal surveillance beginning at 36 0/7 weeks of gestation (GRADE 1C recommendation)

  3. Notify pediatric provider at delivery of the prenatal findings 1

Common Pitfalls to Avoid

  • Do not dismiss isolated SUA as benign: Even without other abnormalities, the 4-5 fold increased stillbirth risk demands action
  • Do not order unnecessary aneuploidy testing: If SUA is truly isolated, additional aneuploidy evaluation is not indicated 1
  • Do not skip the cardiac evaluation: Comprehensive cardiac anatomy assessment is essential to confirm the SUA is truly "isolated" 1
  • Do not delay third-trimester surveillance: Growth monitoring and fetal surveillance are critical to reduce preventable stillbirth

Incidence Context

SUA occurs in 0.25-1% of singleton pregnancies and up to 4.6% of twin gestations 1, making it a relatively common finding that requires systematic management rather than dismissal.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.